Is Reata Pharmaceuticals, Inc. (RETA) Going To Reach Wallstreet’s Targets?

Reata Pharmaceuticals, Inc. (RETA) has seen some recent movement in the marketplace and its common shares closed trading at $116.71 yesterday. Investors are starting to take notice of RETA as the common shares traded as high as $117.25 and as low as $114.07 in the last market day.

Reata Pharmaceuticals, Inc. (RETA) average trading volume is 336.87K. However, in the last market day Reata Pharmaceuticals, Inc. (RETA) traded 135,035 shares. The 1st support level on RETA is $112.75 and the 1st upside resistance level on RETA is $176.56. RETA 50 day moving average is $108.35 and RETA two hundred day moving average is $134.30.

Reata Pharmaceuticals, Inc. (RETA) most current performance has been indicated by the recent movement in RETA common shares. RETA has performed 12.82% over the past 30 days, RETA has performed -21.82% over the past 3 months and RETA has shown -43.37% over the past 1 year. Reata Pharmaceuticals, Inc. (RETA) has a 12 month range of $88.17 to $257.96. Reata Pharmaceuticals, Inc. (RETA) is trading 32.37% from its 12 month low and -54.76% from its 12 month high. Reata Pharmaceuticals, Inc. (RETA) is displaying a 12.58% short float displaying the amount short in the float.

RETA has 33.27M shares outstanding and 27.10M shares in the float. Reata Pharmaceuticals, Inc. (RETA) presently has a market cap of $3.95B and income of -343.20M. The EPS next quarter for RETA is -1.98 and projected EPS next year is -34.10%. The market cap of Reata Pharmaceuticals, Inc. (RETA) at $3.95B signifies how many Investors own shares of RETA and is based off the last price ($116.71) of RETA and the amount of shares outstanding (33.27M) with Reata Pharmaceuticals, Inc. (RETA).

Reata Pharmaceuticals, Inc. (RETA) has aggregate cash (mrq) of 610.42M, aggregate cash per share (mrq) of 18.17, aggregate debt of RETA is at 8.66M and aggregate debt/equity (mrq) is 3.74. . Reata Pharmaceuticals, Inc. (RETA) operational cash flow (ttm) is -426.82M, RETA leveraged free cash flow (ttm) is -212.63M.

RETA is trading 3.80% above (bullish) its SMA20, 9.76% above (bullish) its SMA50 and -21.73% below (bearish) its SMA200.

Related Articles

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Fuwei (NASDAQ: FFHL) Plans To Sell Dornier Production Line

Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) recently declared that it will be closing its Dornier line of production as early as possible. Fuwei...

PPG Industries (NYSE: PPG) Announces Accquisition Of Ennis-Flint

PPG Industries, Inc. (NYSE: PPG) is planning to buy Ennis-Flint in a deal valued at nearly $1.15 billion. The decision to acquire Ennis-Flint will...